- MOQ100 Bottle
- FormMounjaro
- Packaging TypePrefilled Pen Injection
- Brand NameLiquid Solution for Subcutaneous Injection
- Model Number7478GHHI3
- Supply TypeExporter, Supplier, Retailer
- Preferred Buyer Location All Countries Except India
Mounjaro 7.5mg Injection is a once-weekly injectable medication containing Tirzepatide, developed by Eli Lilly for adults with type 2 diabetes and obesity. It acts as a dual GIP and GLP-1 receptor agonist, helping to regulate blood sugar, suppress appetite, and promote weight loss while supporting overall metabolic balance.
View More Details